Allergan Inc. (NYSE:AGN.)

The financial data shows significant fluctuations in various income and comprehensive income components over the five-year period.

Net Earnings

Net earnings increased dramatically from 4,900 thousand US dollars in 2010 to 938,100 thousand in 2011, continuing to grow moderately in 2012 to 1,102,500 thousand. There was a slight decline in 2013 to 988,700 thousand, followed by a substantial rise to 1,528,800 thousand in 2014. This indicates robust overall profitability with some variability in 2013.

Foreign Currency Translation Adjustments

These adjustments were generally negative across the period, starting at -3,200 thousand in 2010, worsening considerably to -42,600 thousand in 2011. The value turned positive in 2012 (9,600 thousand) but fell again to -8,600 thousand in 2013 and declined further to -119,600 thousand in 2014, suggesting increased foreign exchange losses especially in the last year.

Reclassification Adjustment for Foreign Currency Translation Gains

Data is largely missing except for a negative amount of -9,400 thousand in 2011, indicating a one-time reclassification event impacting that year's foreign currency translation gains.

Unrealized Holding Gain on Available-for-Sale Securities

Values are unavailable except for an amount of 5,800 thousand in 2014, which suggests a positive revaluation in that year.

Amortization of Deferred Holding Gains on Derivatives Designated as Cash Flow Hedges

Consistent small negative values of approximately -700 to -800 thousand are observed each year, showing steady amortization expenses related to derivatives.

Net Gain (Loss), Net of Tax

A predominantly negative trend is seen here. Starting with -53,500 thousand in 2010, the losses deepen to -62,700 thousand in 2011 but improve somewhat to -35,900 thousand in 2012. The year 2013 presents a small positive gain of 9,100 thousand, followed by a steep return to a loss of -72,000 thousand in 2014. This suggests volatility in gains and losses on investments or other items accounted for after tax.

Net Gain on Remeasurement of Postretirement Benefit Plan Liability, Net of Tax

Data is sparse, with a 13,100 thousand gain reported only in 2011, indicating a favorable adjustment to plan liabilities that year.

Additional Net Prior Service Cost Due to Plan Amendments, Net of Tax

A single negative amount of -17,800 thousand in 2014 indicates increased costs related to benefit plan amendments in that year.

Amortization, Net of Tax

Amortization shows an overall upward trend, from 8,200 thousand in 2010 to 22,100 thousand in 2014, with a peak in 2012 at 25,100 thousand. This pattern points to rising amortization expenses over time.

Pension and Postretirement Benefit Plan Adjustments

Amounts fluctuate widely, starting with -45,300 thousand in 2010 improving gradually to -10,800 thousand in 2012, then reversing to a positive 23,300 thousand in 2013, and falling sharply to -67,700 thousand in 2014. This suggests considerable variability in pension-related adjustments and potential volatility in plan valuations or assumptions.

Other Comprehensive Income (Loss), Net of Tax

The other comprehensive income exhibits significant fluctuations. From a loss of -49,300 thousand in 2010 to an even greater loss of -89,700 thousand in 2011, it improves to a minor loss of -1,900 thousand in 2012 and reaches a positive 13,900 thousand in 2013. However, it declines sharply to -182,300 thousand in 2014, indicating notable comprehensive losses predominantly in the last year.

Comprehensive Income (Loss)

Comprehensive income follows the trend of net earnings, moving from a negative -44,400 thousand in 2010 to a large positive 848,400 thousand in 2011 and continuing to improve moderately thereafter, with 1,346,500 thousand reported in 2014. This suggests strong overall performance when combining net earnings and other comprehensive items.

Comprehensive Income Attributable to Noncontrolling Interest

Values are negative but relatively small in magnitude across all years, ranging from -5,100 thousand in 2010 to -4,300 thousand in 2014, showing minor losses attributable to noncontrolling interests.

Comprehensive Income (Loss) Attributable to Allergan, Inc.

Following the overall comprehensive income pattern, it shifts from a loss of -49,500 thousand in 2010 to a consistent and considerable increase in subsequent years, reaching 1,342,200 thousand in 2014. This highlights that majority ownership enjoyed positive comprehensive income growth.